BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23271805)

  • 21. Structural principles for computational and de novo design of 4Fe-4S metalloproteins.
    Nanda V; Senn S; Pike DH; Rodriguez-Granillo A; Hansen WA; Khare SD; Noy D
    Biochim Biophys Acta; 2016 May; 1857(5):531-538. PubMed ID: 26449207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease.
    Tamir S; Paddock ML; Darash-Yahana-Baram M; Holt SH; Sohn YS; Agranat L; Michaeli D; Stofleth JT; Lipper CH; Morcos F; Cabantchik IZ; Onuchic JN; Jennings PA; Mittler R; Nechushtai R
    Biochim Biophys Acta; 2015 Jun; 1853(6):1294-315. PubMed ID: 25448035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric control in a metalloprotein dramatically alters function.
    Baxter EL; Zuris JA; Wang C; Vo PL; Axelrod HL; Cohen AE; Paddock ML; Nechushtai R; Onuchic JN; Jennings PA
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):948-53. PubMed ID: 23271805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NADPH inhibits [2Fe-2S] cluster protein transfer from diabetes drug target MitoNEET to an apo-acceptor protein.
    Zuris JA; Ali SS; Yeh H; Nguyen TA; Nechushtai R; Paddock ML; Jennings PA
    J Biol Chem; 2012 Apr; 287(15):11649-55. PubMed ID: 22351774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resonance Raman studies of the (His)(Cys)3 2Fe-2S cluster of MitoNEET: comparison to the (Cys)4 mutant and implications of the effects of pH on the labile metal center.
    Tirrell TF; Paddock ML; Conlan AR; Smoll EJ; Nechushtai R; Jennings PA; Kim JE
    Biochemistry; 2009 Jun; 48(22):4747-52. PubMed ID: 19388667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of human mitoNEET reveals distinct groups of iron sulfur proteins.
    Lin J; Zhou T; Ye K; Wang J
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14640-5. PubMed ID: 17766439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competition of zinc ion for the [2Fe-2S] cluster binding site in the diabetes drug target protein mitoNEET.
    Tan G; Landry AP; Dai R; Wang L; Lu J; Ding H
    Biometals; 2012 Dec; 25(6):1177-84. PubMed ID: 22945239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation.
    Hess B; Kutzner C; van der Spoel D; Lindahl E
    J Chem Theory Comput; 2008 Mar; 4(3):435-47. PubMed ID: 26620784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The shadow map: a general contact definition for capturing the dynamics of biomolecular folding and function.
    Noel JK; Whitford PC; Onuchic JN
    J Phys Chem B; 2012 Jul; 116(29):8692-702. PubMed ID: 22536820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strand swapping regulates the iron-sulfur cluster in the diabetes drug target mitoNEET.
    Baxter EL; Jennings PA; Onuchic JN
    Proc Natl Acad Sci U S A; 2012 Feb; 109(6):1955-60. PubMed ID: 22308404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein.
    Zuris JA; Harir Y; Conlan AR; Shvartsman M; Michaeli D; Tamir S; Paddock ML; Onuchic JN; Mittler R; Cabantchik ZI; Jennings PA; Nechushtai R
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13047-52. PubMed ID: 21788481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of the His ligand in mitoNEET stabilizes the 2Fe-2S cluster despite conformational heterogeneity in the ligand environment.
    Conlan AR; Paddock ML; Homer C; Axelrod HL; Cohen AE; Abresch EC; Zuris JA; Nechushtai R; Jennings PA
    Acta Crystallogr D Biol Crystallogr; 2011 Jun; 67(Pt 6):516-23. PubMed ID: 21636891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interdomain communication revealed in the diabetes drug target mitoNEET.
    Baxter EL; Jennings PA; Onuchic JN
    Proc Natl Acad Sci U S A; 2011 Mar; 108(13):5266-71. PubMed ID: 21402934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allostery in the ferredoxin protein motif does not involve a conformational switch.
    Nechushtai R; Lammert H; Michaeli D; Eisenberg-Domovich Y; Zuris JA; Luca MA; Capraro DT; Fish A; Shimshon O; Roy M; Schug A; Whitford PC; Livnah O; Onuchic JN; Jennings PA
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2240-5. PubMed ID: 21266547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head swivel on the ribosome facilitates translocation by means of intra-subunit tRNA hybrid sites.
    Ratje AH; Loerke J; Mikolajka A; Brünner M; Hildebrand PW; Starosta AL; Dönhöfer A; Connell SR; Fucini P; Mielke T; Whitford PC; Onuchic JN; Yu Y; Sanbonmatsu KY; Hartmann RK; Penczek PA; Wilson DN; Spahn CM
    Nature; 2010 Dec; 468(7324):713-6. PubMed ID: 21124459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering the redox potential over a wide range within a new class of FeS proteins.
    Zuris JA; Halim DA; Conlan AR; Abresch EC; Nechushtai R; Paddock ML; Jennings PA
    J Am Chem Soc; 2010 Sep; 132(38):13120-2. PubMed ID: 20812736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accommodation of aminoacyl-tRNA into the ribosome involves reversible excursions along multiple pathways.
    Whitford PC; Geggier P; Altman RB; Blanchard SC; Onuchic JN; Sanbonmatsu KY
    RNA; 2010 Jun; 16(6):1196-204. PubMed ID: 20427512
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.